Grant Larrilyn, Harper Kari, Gentile Julie P
All authors are with the Department of Psychiatry at Wright State University in Dayton, Ohio.
Innov Clin Neurosci. 2025 Jun 1;22(4-6):29-37. eCollection 2025 Apr-Jun.
Julie P. Gentile, MD, is Professor and Chair of the Department of Psychiatry at Wright State University in Dayton, Ohio.
EDITOR’S NOTE: The patient scenarios presented in this article are composite cases written to illustrate certain diagnostic characteristics and to instruct on treatment techniques. The composite cases are not real patients in treatment. Any resemblance to real patients is purely coincidental.
The prevalence of mental illness in individuals with intellectual disability (ID) is higher compared to the general population. Persons with ID typically have insufficient coping skills and fewer systems of natural support; they are often more vulnerable to stress. There is evidence that level of intelligence is not a sole indicator for appropriateness for psychotherapy, and that the full range of mental health services help improve quality of life for patients with ID. Polypharmacy is more common in patients with co-occurring ID and mental illness. It is common for patients with ID to be prescribed multiple medications for both physical and mental health conditions. In addition, when patients are discharged from state-operated institutions to the community, it is common for them to continue taking the same number of medications. This article will review the use of adapted psychotherapy in patients with ID, as well as deprescribing protocols to address polypharmacy.
朱莉·P·詹蒂莱医学博士，是俄亥俄州代顿市赖特州立大学精神病学系教授兼系主任。
本文中呈现的患者案例为综合案例，旨在说明某些诊断特征并指导治疗技术。这些综合案例并非正在接受治疗的真实患者。与真实患者的任何相似之处纯属巧合。
与普通人群相比，智力残疾（ID）个体中精神疾病的患病率更高。ID患者通常应对技能不足且自然支持系统较少；他们往往更容易受到压力影响。有证据表明，智力水平并非心理治疗适用性的唯一指标，而且全方位的心理健康服务有助于改善ID患者的生活质量。多重用药在同时患有ID和精神疾病的患者中更为常见。ID患者因身心健康状况而被开具多种药物的情况很常见。此外，当患者从国立机构出院进入社区时，他们继续服用相同数量药物的情况也很常见。本文将回顾适应性心理治疗在ID患者中的应用，以及解决多重用药问题的减药方案。
